Yesterday it was reported that the Executive V P& CFO of Omnicell (OMCL – Research Report), Kuipers Peter, exercised options to sell 13,000 OMCL shares at $41.27 a share, for a total transaction value of $1.06M. In addition to Kuipers
Today, the President of Omnicell (OMCL – Research Report), Robin Gene Seim, sold shares of OMCL for $2.41M. Following Robin Gene Seim’s last OMCL Sell transaction on June 04, 2018, the stock climbed by 35.0%. In addition to Robin Gene
Today it was reported that the EVP, Global R & D of Omnicell (OMCL – Research Report), Jorge Taborga, exercised options to sell 19,796 OMCL shares at $1132.54 a share, for a total transaction value of $1.66M. Following Jorge Taborga’s
Today, the Executive V P& CFO of Omnicell (OMCL – Research Report), Kuipers Peter, sold shares of OMCL for $1.87M. Following Kuipers Peter J.’s last OMCL Sell transaction on December 10, 2018, the stock climbed by 13.4%. In addition to
Oppenheimer analyst Mohan Naidu maintained a Buy rating on Omnicell (OMCL – Research Report) today and set a price target of $86. The company’s shares closed yesterday at $70.59. Naidu noted: “Review of OMCL’s products and the discussion with management
Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on Omnicell (OMCL – Research Report) today and set a price target of $80. The company’s shares opened today at $70.59. Halper noted: “. We continue to rate OMCL shares at